Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Adriana Weinberg

Concepts (834)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
101
2026
3186
10.050
 Why?
Herpes Zoster Vaccine
26
2026
154
9.910
 Why?
Herpes Zoster
33
2025
318
9.140
 Why?
Herpesvirus 3, Human
37
2025
341
7.230
 Why?
Influenza Vaccines
29
2021
534
5.830
 Why?
Cytomegalovirus Infections
28
2024
206
5.790
 Why?
Immunity, Cellular
34
2025
273
5.560
 Why?
Antibodies, Viral
44
2024
673
5.200
 Why?
Pregnancy Complications, Infectious
27
2026
438
5.080
 Why?
T-Lymphocytes, Regulatory
15
2025
407
4.560
 Why?
Cytomegalovirus
27
2024
168
4.200
 Why?
Influenza, Human
27
2021
624
3.900
 Why?
Respiratory Syncytial Virus, Human
7
2026
81
3.340
 Why?
Antiretroviral Therapy, Highly Active
22
2017
279
2.780
 Why?
Immunologic Memory
15
2026
368
2.550
 Why?
Influenza A Virus, H1N1 Subtype
13
2021
159
2.510
 Why?
Pneumococcal Infections
4
2022
103
2.480
 Why?
Vaccines, Attenuated
23
2024
129
2.470
 Why?
Anti-HIV Agents
19
2026
908
2.450
 Why?
T-Lymphocyte Subsets
12
2019
417
2.440
 Why?
T-Lymphocytes
22
2020
1993
2.380
 Why?
Leukocytes, Mononuclear
16
2025
573
2.260
 Why?
CD4-Positive T-Lymphocytes
29
2023
1138
2.050
 Why?
Respiratory Tract Infections
7
2025
394
2.030
 Why?
Respiratory Syncytial Virus Infections
3
2026
139
1.960
 Why?
Isoniazid
7
2026
70
1.680
 Why?
Vaccination
23
2024
1423
1.660
 Why?
Chickenpox
8
2024
82
1.600
 Why?
Humans
241
2026
145140
1.570
 Why?
Antiviral Agents
17
2023
767
1.540
 Why?
Latent Tuberculosis
2
2026
70
1.520
 Why?
Chickenpox Vaccine
11
2024
75
1.520
 Why?
Interferon-gamma
20
2022
784
1.520
 Why?
Tuberculosis
7
2026
283
1.490
 Why?
Pregnancy
46
2026
7182
1.470
 Why?
Female
167
2026
78636
1.450
 Why?
Drug Resistance, Viral
14
2017
124
1.410
 Why?
HIV
8
2022
251
1.390
 Why?
CD8-Positive T-Lymphocytes
12
2019
917
1.330
 Why?
Antitubercular Agents
5
2026
208
1.320
 Why?
Virus Diseases
4
2018
216
1.320
 Why?
Infant
44
2026
10060
1.300
 Why?
DNA, Viral
13
2024
355
1.290
 Why?
Mycobacterium tuberculosis
2
2026
318
1.280
 Why?
Tetanus Toxoid
4
2021
34
1.270
 Why?
Virus Shedding
6
2017
48
1.240
 Why?
Infectious Disease Transmission, Vertical
10
2023
194
1.210
 Why?
Adult
103
2026
40665
1.200
 Why?
Influenza A virus
9
2013
116
1.170
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
9
2009
28
1.160
 Why?
Vaccines, Synthetic
8
2026
137
1.160
 Why?
Influenza B virus
9
2017
47
1.150
 Why?
Hepatitis A Vaccines
5
2020
19
1.120
 Why?
Antibodies, Bacterial
5
2022
147
1.110
 Why?
Dermatitis, Atopic
5
2020
322
1.080
 Why?
Male
127
2026
72664
1.080
 Why?
B-Lymphocytes
7
2021
866
1.070
 Why?
Cord Blood Stem Cell Transplantation
3
2023
103
1.060
 Why?
Adjuvants, Immunologic
8
2021
243
1.050
 Why?
CD4 Lymphocyte Count
17
2019
280
0.990
 Why?
HIV-1
13
2019
906
0.990
 Why?
Antibody Formation
7
2023
287
0.980
 Why?
Hemagglutination Inhibition Tests
14
2021
38
0.970
 Why?
Infant, Newborn
26
2026
6435
0.960
 Why?
Pneumococcal Vaccines
3
2022
129
0.960
 Why?
Transforming Growth Factor beta
4
2025
474
0.940
 Why?
Anti-Retroviral Agents
8
2023
251
0.940
 Why?
Lymphocyte Activation
26
2020
1131
0.940
 Why?
Breast Feeding
4
2023
446
0.910
 Why?
Gastrointestinal Microbiome
2
2025
766
0.910
 Why?
Transforming Growth Factor beta1
2
2025
176
0.910
 Why?
Interleukin-2
13
2022
440
0.890
 Why?
Monocytes
2
2025
537
0.870
 Why?
Vaccines, Inactivated
10
2017
70
0.870
 Why?
Respiratory Syncytial Viruses
1
2025
58
0.860
 Why?
Enzyme-Linked Immunospot Assay
6
2018
37
0.860
 Why?
Viral Load
18
2023
525
0.850
 Why?
Viremia
9
2021
160
0.840
 Why?
Hematopoietic Stem Cell Transplantation
3
2023
698
0.840
 Why?
HIV Protease Inhibitors
3
2019
69
0.810
 Why?
Child, Preschool
35
2025
11835
0.790
 Why?
Immune Reconstitution
1
2023
10
0.790
 Why?
Child
54
2025
22670
0.780
 Why?
Epstein-Barr Virus Infections
5
2013
101
0.780
 Why?
Environmental Exposure
2
2018
577
0.750
 Why?
Papillomavirus Vaccines
3
2018
296
0.750
 Why?
Double-Blind Method
18
2026
2057
0.740
 Why?
Cytokines
13
2026
2048
0.740
 Why?
Receptors, Tumor Necrosis Factor
8
2001
161
0.710
 Why?
Herpesvirus 1, Human
3
2016
84
0.710
 Why?
Adolescent
54
2025
22479
0.700
 Why?
Polymerase Chain Reaction
12
2023
1039
0.680
 Why?
Orthomyxoviridae
3
2017
40
0.680
 Why?
Middle Aged
64
2026
36126
0.680
 Why?
Young Adult
30
2026
14176
0.670
 Why?
Aged
43
2026
26096
0.650
 Why?
DNA-Directed DNA Polymerase
4
2008
48
0.640
 Why?
Vitamin D
2
2024
403
0.630
 Why?
Viral Proteins
5
2012
350
0.620
 Why?
Aged, 80 and over
18
2022
8318
0.620
 Why?
Rotavirus Infections
2
2017
37
0.620
 Why?
Rotavirus Vaccines
2
2017
39
0.620
 Why?
Herpesvirus 4, Human
8
2014
172
0.610
 Why?
Postpartum Period
7
2026
372
0.610
 Why?
Immunosuppressive Agents
7
2014
837
0.600
 Why?
Killer Cells, Natural
5
2026
478
0.600
 Why?
Viral Envelope Proteins
2
2021
98
0.590
 Why?
Medroxyprogesterone Acetate
2
2016
33
0.580
 Why?
Respiratory Syncytial Virus Vaccines
1
2019
39
0.570
 Why?
Inflammation
5
2026
2876
0.570
 Why?
RNA, Viral
9
2024
690
0.560
 Why?
Antibodies, Neutralizing
7
2021
340
0.560
 Why?
Paramyxoviridae Infections
2
2011
12
0.560
 Why?
Simplexvirus
9
2016
82
0.550
 Why?
Human papillomavirus 18
1
2018
12
0.550
 Why?
Immunocompromised Host
9
2019
202
0.540
 Why?
Human papillomavirus 16
1
2018
27
0.540
 Why?
Hepatitis A Antibodies
2
2009
3
0.540
 Why?
Cryopreservation
2
2010
113
0.540
 Why?
AIDS-Related Opportunistic Infections
3
2019
130
0.530
 Why?
Th1 Cells
1
2018
139
0.530
 Why?
Lymphocyte Subsets
2
2015
77
0.520
 Why?
Flow Cytometry
11
2019
1159
0.510
 Why?
Antigens, Viral
8
2017
182
0.510
 Why?
Immunization, Secondary
6
2017
92
0.500
 Why?
Immunity, Innate
3
2026
834
0.500
 Why?
Immunoconjugates
2
2013
138
0.500
 Why?
Age Factors
9
2019
3338
0.500
 Why?
Mutation
7
2009
4071
0.500
 Why?
Hospitalization
6
2021
2458
0.490
 Why?
Acyclovir
6
2012
97
0.490
 Why?
Herpesviridae Infections
5
2013
148
0.480
 Why?
Encephalomyelitis, Autoimmune, Experimental
5
1999
68
0.480
 Why?
Premature Birth
2
2019
387
0.470
 Why?
Case-Control Studies
14
2024
3616
0.470
 Why?
Host-Pathogen Interactions
1
2019
361
0.470
 Why?
Immunoglobulin G
8
2026
887
0.470
 Why?
Viral Vaccines
4
2014
107
0.460
 Why?
Herpes Simplex
4
2016
98
0.450
 Why?
T-Lymphocytes, Cytotoxic
3
2011
177
0.450
 Why?
Reagent Kits, Diagnostic
2
2005
33
0.440
 Why?
Contraceptive Agents, Female
1
2016
80
0.430
 Why?
Central Nervous System Viral Diseases
3
2004
78
0.430
 Why?
B-Lymphocyte Subsets
1
2015
76
0.420
 Why?
Immunoassay
5
2017
109
0.420
 Why?
Immunity, Mucosal
2
2012
98
0.420
 Why?
Injections, Intramuscular
4
2017
146
0.410
 Why?
Foscarnet
6
2008
21
0.410
 Why?
Immunophenotyping
6
2019
318
0.400
 Why?
Transplant Recipients
3
2024
180
0.390
 Why?
Gene Expression Profiling
3
2019
1763
0.390
 Why?
Antigen-Presenting Cells
4
2022
159
0.390
 Why?
B-Lymphocytes, Regulatory
1
2013
3
0.390
 Why?
CD4 Antigens
2
2011
137
0.380
 Why?
Abatacept
3
2026
56
0.380
 Why?
Influenza A Virus, H3N2 Subtype
4
2020
50
0.370
 Why?
Reverse Transcriptase Inhibitors
3
2020
87
0.370
 Why?
Staphylococcus aureus
1
2017
451
0.370
 Why?
Immune Tolerance
2
2013
385
0.370
 Why?
Alphapapillomavirus
1
2012
35
0.370
 Why?
Dendritic Cells
2
2026
496
0.360
 Why?
Vaccines, Conjugate
2
2022
59
0.360
 Why?
Cell Proliferation
6
2020
2504
0.360
 Why?
Hepatitis A
1
2012
25
0.360
 Why?
Candida
3
2010
45
0.360
 Why?
Placebos
5
2017
193
0.350
 Why?
Cohort Studies
11
2023
5988
0.350
 Why?
Polysaccharides
2
2022
86
0.350
 Why?
Skin
1
2017
753
0.350
 Why?
CD28 Antigens
3
2009
59
0.350
 Why?
Contraceptive Agents
1
2012
65
0.340
 Why?
Metapneumovirus
1
2011
15
0.340
 Why?
Transplantation
1
2011
33
0.340
 Why?
Herpesvirus 2, Human
2
2012
27
0.340
 Why?
Lymphocyte Count
4
2019
163
0.340
 Why?
Lymphoproliferative Disorders
1
2011
57
0.340
 Why?
Benzoxazines
4
2026
31
0.340
 Why?
T-Lymphocytes, Helper-Inducer
7
1994
132
0.330
 Why?
Blood
2
2009
107
0.330
 Why?
Immunogenicity, Vaccine
5
2026
36
0.330
 Why?
Nucleosides
1
2010
25
0.330
 Why?
Drug Therapy, Combination
6
2019
1043
0.320
 Why?
Retrospective Studies
21
2024
17247
0.320
 Why?
Pregnancy Outcome
7
2021
500
0.320
 Why?
Immunoglobulin A
4
2017
214
0.310
 Why?
Programmed Cell Death 1 Receptor
3
2020
264
0.310
 Why?
Cytosine
3
2008
49
0.310
 Why?
Streptococcus pneumoniae
2
2022
180
0.310
 Why?
Adaptive Immunity
2
2017
167
0.310
 Why?
Glycoproteins
2
2023
354
0.310
 Why?
Nucleotides
1
2010
129
0.310
 Why?
Antidepressive Agents
3
2021
239
0.310
 Why?
Refrigeration
1
2009
11
0.300
 Why?
Enzyme-Linked Immunosorbent Assay
8
2021
847
0.300
 Why?
Immunity, Humoral
2
2021
118
0.300
 Why?
Membrane Glycoproteins
4
2001
499
0.300
 Why?
Follow-Up Studies
16
2024
5411
0.300
 Why?
Organophosphonates
3
2008
95
0.300
 Why?
Astrocytes
1
2011
228
0.290
 Why?
Prospective Studies
15
2026
8035
0.290
 Why?
Freezing
1
2009
83
0.290
 Why?
Coculture Techniques
2
2025
247
0.290
 Why?
Cytomegalovirus Retinitis
2
2013
22
0.280
 Why?
Tetanus
2
2009
26
0.280
 Why?
Cyclopropanes
4
2026
84
0.280
 Why?
Alkynes
4
2026
67
0.280
 Why?
Fetal Blood
3
2026
325
0.280
 Why?
Lopinavir
3
2023
30
0.280
 Why?
Interleukin-10
3
2022
309
0.280
 Why?
Biomarkers
8
2026
4282
0.270
 Why?
Time Factors
18
2017
7107
0.270
 Why?
Herpesvirus 7, Human
2
2005
6
0.270
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2008
100
0.270
 Why?
Herpesvirus 6, Human
2
2005
14
0.270
 Why?
Glioblastoma
1
2011
352
0.260
 Why?
Longitudinal Studies
8
2019
2949
0.260
 Why?
Norgestrel
1
2007
2
0.260
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
977
0.260
 Why?
Specimen Handling
1
2009
182
0.260
 Why?
Interleukins
2
2008
248
0.260
 Why?
Apoptosis
6
2011
2434
0.250
 Why?
Incidence
9
2023
2915
0.240
 Why?
Nucleic Acid Hybridization
2
2006
187
0.240
 Why?
Antigens, CD
5
2017
558
0.240
 Why?
Lung Transplantation
4
2002
329
0.230
 Why?
Acetates
2
2023
78
0.230
 Why?
Coinfection
2
2019
143
0.230
 Why?
Lymphokines
5
1994
128
0.230
 Why?
Fibroblasts
4
2025
1022
0.220
 Why?
Bone Marrow Transplantation
2
2005
297
0.220
 Why?
Ritonavir
2
2016
75
0.220
 Why?
A549 Cells
1
2025
74
0.220
 Why?
Dexamethasone
1
2007
365
0.220
 Why?
Cell Survival
5
2010
1100
0.220
 Why?
Receptors, OX40
8
2001
15
0.220
 Why?
Roseolovirus Infections
1
2004
8
0.210
 Why?
Paramyxoviridae
1
2004
2
0.210
 Why?
Virus Replication
5
2017
519
0.210
 Why?
Measles Vaccine
1
2024
19
0.210
 Why?
Chemical and Drug Induced Liver Injury
1
2026
138
0.210
 Why?
Quinazolines
2
2023
266
0.210
 Why?
RNA, Messenger
10
2011
2803
0.210
 Why?
BCG Vaccine
2
2023
27
0.200
 Why?
Ganciclovir
4
2008
53
0.200
 Why?
Autoimmune Diseases
3
2014
468
0.200
 Why?
Forkhead Transcription Factors
3
2011
207
0.200
 Why?
Milk, Human
2
2023
174
0.200
 Why?
Immunity
2
2020
140
0.200
 Why?
Brazil
2
2021
179
0.200
 Why?
Cholecalciferol
1
2024
61
0.200
 Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
261
0.200
 Why?
Estradiol
1
2007
512
0.200
 Why?
Myelin Basic Protein
4
1998
44
0.200
 Why?
Orthomyxoviridae Infections
1
2004
71
0.200
 Why?
Down-Regulation
1
2025
618
0.200
 Why?
Maternal-Fetal Exchange
2
2016
170
0.190
 Why?
Acquired Immunodeficiency Syndrome
2
2023
237
0.190
 Why?
Papillomavirus Infections
2
2018
343
0.190
 Why?
Kaposi Varicelliform Eruption
3
2011
21
0.190
 Why?
Abnormalities, Drug-Induced
1
2023
38
0.190
 Why?
Long-Term Care
1
2024
117
0.190
 Why?
Antirheumatic Agents
1
2026
307
0.190
 Why?
Adenoviridae Infections
1
2023
20
0.190
 Why?
Heart Transplantation
10
2001
675
0.190
 Why?
Isoxazoles
2
2013
55
0.180
 Why?
Zidovudine
2
2015
77
0.180
 Why?
Diabetes Mellitus, Type 1
4
2013
3918
0.180
 Why?
Lamivudine
2
2015
65
0.180
 Why?
Herpes Genitalis
2
2012
17
0.180
 Why?
HIV Integrase Inhibitors
1
2023
79
0.180
 Why?
Liver Failure, Acute
1
2023
68
0.180
 Why?
United States
9
2024
16065
0.180
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
95
0.180
 Why?
Genes, Immediate-Early
1
2002
26
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Risk Factors
18
2024
10857
0.180
 Why?
Genes, Viral
1
2002
88
0.180
 Why?
Central Nervous System Diseases
1
2002
74
0.180
 Why?
Antigens, Differentiation
1
2001
76
0.170
 Why?
Tuberculin Test
1
2021
36
0.170
 Why?
South Africa
6
2020
266
0.170
 Why?
Biliary Atresia
1
2023
158
0.170
 Why?
Interferon-gamma Release Tests
1
2021
32
0.170
 Why?
Cytotoxicity, Immunologic
2
2002
224
0.170
 Why?
Prenatal Exposure Delayed Effects
2
2026
650
0.170
 Why?
Maternal Exposure
1
2023
188
0.170
 Why?
Phenotype
7
2009
3138
0.170
 Why?
Cells, Cultured
11
2010
4142
0.170
 Why?
Organ Transplantation
1
2024
250
0.170
 Why?
Treatment Outcome
17
2026
11741
0.170
 Why?
Atazanavir Sulfate
2
2023
42
0.170
 Why?
Medication Therapy Management
1
2021
72
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
 Why?
Evolution, Molecular
1
2005
490
0.160
 Why?
Immunoglobulins
2
2017
161
0.160
 Why?
Virus Activation
3
2013
94
0.160
 Why?
Receptors, Immunologic
2
2000
208
0.160
 Why?
North America
2
2023
301
0.160
 Why?
Sensitivity and Specificity
5
2009
1995
0.160
 Why?
HIV Seronegativity
1
2020
29
0.160
 Why?
Histocompatibility Antigens Class I
1
2002
202
0.160
 Why?
RNA, Ribosomal, 16S
1
2022
507
0.160
 Why?
Virus Cultivation
3
2005
31
0.160
 Why?
Dietary Supplements
1
2024
582
0.150
 Why?
Heart-Assist Devices
8
2000
568
0.150
 Why?
T-Cell Antigen Receptor Specificity
1
2019
45
0.150
 Why?
Interleukin-2 Receptor alpha Subunit
1
2019
82
0.150
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
2017
13
0.150
 Why?
Eicosanoids
1
2019
58
0.150
 Why?
Survival Analysis
6
2018
1371
0.150
 Why?
Dose-Response Relationship, Immunologic
2
2016
76
0.140
 Why?
Cholera Toxin
1
2018
29
0.140
 Why?
Arthritis, Rheumatoid
2
2026
1174
0.140
 Why?
Hospitals
1
2023
732
0.140
 Why?
Postoperative Complications
14
2001
2961
0.140
 Why?
Saliva
2
2010
245
0.140
 Why?
Genotype
6
2020
1844
0.140
 Why?
Delayed-Action Preparations
2
2016
187
0.130
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.130
 Why?
Latin America
1
2018
96
0.130
 Why?
Cell Movement
2
2001
959
0.130
 Why?
Neurodevelopmental Disorders
1
2021
226
0.130
 Why?
CD4-CD8 Ratio
2
2008
23
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Vaccination Coverage
1
2018
102
0.130
 Why?
Cell Line
5
2009
2821
0.130
 Why?
Injections, Intradermal
1
2017
11
0.130
 Why?
Coronary Artery Bypass
4
2001
268
0.130
 Why?
Injections, Subcutaneous
2
2016
170
0.130
 Why?
Paralysis
1
2017
69
0.120
 Why?
Nervous System Diseases
1
2020
286
0.120
 Why?
Arm
1
2017
110
0.120
 Why?
Kinetics
3
2010
1567
0.120
 Why?
Seroconversion
1
2017
48
0.120
 Why?
Placenta
2
2021
784
0.120
 Why?
Africa
1
2017
118
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Adoptive Transfer
3
2002
199
0.120
 Why?
Animals
24
2011
37952
0.120
 Why?
Clinical Trials as Topic
2
2019
1058
0.120
 Why?
Base Sequence
6
2017
2168
0.120
 Why?
Cross Reactions
2
2014
130
0.120
 Why?
Demography
2
2018
282
0.120
 Why?
Colorado
2
2023
4538
0.110
 Why?
Seizures
1
2020
482
0.110
 Why?
RNA
1
2022
910
0.110
 Why?
Liver Transplantation
1
2023
826
0.110
 Why?
Comorbidity
2
2019
1657
0.110
 Why?
Aging
3
2017
1962
0.110
 Why?
Nevirapine
1
2015
18
0.110
 Why?
Contraceptives, Oral, Synthetic
1
2015
1
0.110
 Why?
Nasopharynx
1
2015
72
0.110
 Why?
Nasal Lavage Fluid
2
2005
15
0.110
 Why?
Immunoenzyme Techniques
2
2006
200
0.110
 Why?
Infant, Newborn, Diseases
1
2016
115
0.110
 Why?
Transcription, Genetic
1
2021
1454
0.110
 Why?
Virus Latency
2
2013
90
0.110
 Why?
Skin Diseases
1
2016
152
0.100
 Why?
Neutropenia
1
2015
154
0.100
 Why?
Seroepidemiologic Studies
2
2024
171
0.100
 Why?
Multivariate Analysis
5
2017
1546
0.100
 Why?
Computational Biology
1
2019
669
0.100
 Why?
Pandemics
2
2021
1703
0.100
 Why?
Graft Rejection
5
2001
518
0.100
 Why?
Antigens, Differentiation, T-Lymphocyte
1
1994
104
0.100
 Why?
Physical Fitness
1
2015
207
0.100
 Why?
Herpesvirus 8, Human
2
2005
67
0.100
 Why?
Progesterone
2
2015
214
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
 Why?
Feces
1
2017
494
0.100
 Why?
Anemia
1
2015
190
0.100
 Why?
Thrombocytopenia
1
2015
204
0.100
 Why?
Leukocyte Common Antigens
2
2009
87
0.090
 Why?
Epitopes
2
2009
473
0.090
 Why?
Anesthesiology
1
2016
178
0.090
 Why?
Epitopes, T-Lymphocyte
1
2014
174
0.090
 Why?
Polyomavirus Infections
1
2013
30
0.090
 Why?
Tumor Virus Infections
1
2013
50
0.090
 Why?
Mothers
1
2019
764
0.090
 Why?
OX40 Ligand
4
2001
10
0.090
 Why?
Transcriptome
1
2019
1029
0.090
 Why?
Proctitis
1
2012
6
0.090
 Why?
Oxadiazoles
1
2012
37
0.090
 Why?
HIV Seropositivity
1
2013
119
0.090
 Why?
Oxidative Stress
1
2019
1351
0.090
 Why?
Rats, Inbred Lew
4
1998
104
0.090
 Why?
Aprotinin
3
1997
9
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
DNA Primase
1
2012
47
0.090
 Why?
Depression
1
2021
1537
0.090
 Why?
Mycophenolic Acid
1
2012
120
0.090
 Why?
Communicable Diseases
1
2014
166
0.090
 Why?
Fluorescent Antibody Technique, Direct
1
2011
9
0.090
 Why?
Viral Plaque Assay
3
2006
29
0.090
 Why?
L-Selectin
2
2009
27
0.090
 Why?
Receptors, Interleukin-2
2
1990
64
0.080
 Why?
Histocompatibility Testing
3
2001
123
0.080
 Why?
CD8 Antigens
1
2011
70
0.080
 Why?
Guanine
3
2006
85
0.080
 Why?
Encephalitis, Viral
2
2020
45
0.080
 Why?
Ribavirin
1
2011
81
0.080
 Why?
Immunization Schedule
3
2020
186
0.080
 Why?
DNA Helicases
1
2012
136
0.080
 Why?
Fluorescent Antibody Technique
2
2016
365
0.080
 Why?
Motor Activity
1
2015
718
0.080
 Why?
Parturition
1
2011
68
0.080
 Why?
Predictive Value of Tests
3
2005
2115
0.080
 Why?
Logistic Models
5
2010
2133
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Length of Stay
3
2014
1348
0.080
 Why?
Menstrual Cycle
1
2011
145
0.080
 Why?
Algorithms
3
2021
1845
0.080
 Why?
Immune System
2
2008
177
0.080
 Why?
Granzymes
1
2009
49
0.080
 Why?
Herpes Simplex Virus Vaccines
1
2009
4
0.080
 Why?
Pokeweed Mitogens
1
2009
6
0.080
 Why?
Human Experimentation
1
2009
12
0.070
 Why?
Neuralgia, Postherpetic
1
2009
40
0.070
 Why?
Pilot Projects
2
2026
1889
0.070
 Why?
Immunologic Factors
1
2011
260
0.070
 Why?
Drug Stability
1
2009
169
0.070
 Why?
Plasma
2
2018
223
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
187
0.070
 Why?
Tumor Necrosis Factor-alpha
1
2014
1216
0.070
 Why?
Gene Rearrangement, T-Lymphocyte
1
2008
16
0.070
 Why?
Cost of Illness
1
2011
324
0.070
 Why?
Nasal Mucosa
1
2009
112
0.070
 Why?
Inflammation Mediators
1
2011
506
0.070
 Why?
Mice
13
2011
18303
0.070
 Why?
Enzyme Inhibitors
1
2012
820
0.070
 Why?
Botswana
2
2019
11
0.070
 Why?
Genetic Variation
2
2011
967
0.070
 Why?
Betaherpesvirinae
1
2008
1
0.070
 Why?
Infant Mortality
2
2019
128
0.070
 Why?
Exodeoxyribonucleases
1
2008
23
0.070
 Why?
Administration, Intranasal
1
2008
94
0.070
 Why?
Interleukin-15
1
2008
95
0.070
 Why?
Cyclosporine
2
2001
256
0.070
 Why?
Interleukin-12
1
2008
115
0.070
 Why?
Rats
5
1998
5582
0.070
 Why?
Trypan Blue
1
2007
5
0.070
 Why?
Didanosine
1
2007
13
0.070
 Why?
Sarcoma
1
2010
204
0.070
 Why?
Thymus Gland
1
2008
311
0.070
 Why?
Gene Expression
3
2006
1474
0.060
 Why?
In Vitro Techniques
3
2006
1048
0.060
 Why?
Data Interpretation, Statistical
1
2009
368
0.060
 Why?
Quality Control
1
2007
161
0.060
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2010
296
0.060
 Why?
Cerebrospinal Fluid
2
2004
88
0.060
 Why?
Vero Cells
1
2006
83
0.060
 Why?
Inhibitory Concentration 50
1
2006
90
0.060
 Why?
Pneumonia
1
2013
635
0.060
 Why?
Transfection
3
2002
926
0.060
 Why?
Drug Interactions
2
2020
404
0.060
 Why?
Multicenter Studies as Topic
2
2006
410
0.060
 Why?
Randomized Controlled Trials as Topic
2
2011
1742
0.060
 Why?
Veterans
1
2018
1625
0.060
 Why?
Antibodies, Monoclonal, Humanized
1
2012
992
0.060
 Why?
Deoxycytidine
1
2007
220
0.060
 Why?
Protein Structure, Tertiary
1
2008
855
0.060
 Why?
Opportunistic Infections
2
2014
47
0.060
 Why?
Hemadsorption
1
2005
1
0.060
 Why?
Cytopathogenic Effect, Viral
1
2005
16
0.060
 Why?
Tumor Necrosis Factors
3
2001
10
0.060
 Why?
Hemostatics
2
1997
64
0.060
 Why?
Disease Models, Animal
2
2011
4552
0.060
 Why?
Risk Assessment
2
2014
3740
0.060
 Why?
Signal Transduction
2
2000
5208
0.060
 Why?
Evaluation Studies as Topic
1
2005
164
0.060
 Why?
Gene Products, pol
1
2005
6
0.060
 Why?
Annexin A5
1
2004
23
0.050
 Why?
Clinical Trials, Phase II as Topic
2
2017
75
0.050
 Why?
Cysteine Proteinase Inhibitors
1
2004
49
0.050
 Why?
Antigens
2
2008
348
0.050
 Why?
Meningitis, Viral
1
2004
20
0.050
 Why?
Parainfluenza Virus 2, Human
1
2004
3
0.050
 Why?
Pharmacogenetics
1
2026
174
0.050
 Why?
Parainfluenza Virus 1, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 3, Human
1
2004
5
0.050
 Why?
Sarcoma, Kaposi
2
2003
83
0.050
 Why?
Measles virus
1
2024
21
0.050
 Why?
Disease Transmission, Infectious
1
2005
69
0.050
 Why?
Transplantation, Homologous
2
2002
417
0.050
 Why?
Adenoviruses, Human
1
2004
26
0.050
 Why?
Emtricitabine
2
2021
209
0.050
 Why?
Cell Culture Techniques
1
2006
372
0.050
 Why?
Fatal Outcome
1
2005
305
0.050
 Why?
Immunotherapy, Adoptive
2
2001
342
0.050
 Why?
Chlamydophila Infections
1
2003
5
0.050
 Why?
Chlamydophila pneumoniae
1
2003
12
0.050
 Why?
Measles
1
2024
46
0.050
 Why?
HLA-DR Antigens
3
2001
220
0.050
 Why?
Rilpivirine
1
2023
10
0.050
 Why?
Bronchiolitis Obliterans
2
2001
61
0.050
 Why?
Survival Rate
8
2001
2087
0.050
 Why?
Arteriosclerosis
1
2003
83
0.050
 Why?
Portoenterostomy, Hepatic
1
2023
43
0.050
 Why?
Darunavir
1
2023
20
0.050
 Why?
Herpes Labialis
1
2003
8
0.050
 Why?
Cell Line, Tumor
1
2011
3539
0.050
 Why?
Hospital Mortality
4
2001
1038
0.050
 Why?
Leukemia, Myeloid, Acute
1
2010
686
0.050
 Why?
DNA Primers
3
2009
505
0.050
 Why?
Respirovirus
1
2002
6
0.050
 Why?
Pregnancy Trimester, First
1
2023
138
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
2
1994
333
0.050
 Why?
Bronchoalveolar Lavage Fluid
1
2005
638
0.040
 Why?
Risk
1
2005
916
0.040
 Why?
Parapsychology
1
2001
1
0.040
 Why?
Adenoviridae
1
2023
199
0.040
 Why?
Electromagnetic Fields
1
2001
37
0.040
 Why?
Zimbabwe
2
2017
76
0.040
 Why?
B7-1 Antigen
2
1998
55
0.040
 Why?
Microbial Sensitivity Tests
1
2003
363
0.040
 Why?
Molecular Sequence Data
4
1994
2881
0.040
 Why?
Ovalbumin
1
2001
194
0.040
 Why?
Cobicistat
1
2021
5
0.040
 Why?
Receptors, CXCR5
1
2021
27
0.040
 Why?
Antibody Affinity
1
2021
60
0.040
 Why?
Rituximab
2
2013
210
0.040
 Why?
CTLA-4 Antigen
1
2001
105
0.040
 Why?
Photography
1
2001
119
0.040
 Why?
Liver Diseases
1
2024
304
0.040
 Why?
Prostheses and Implants
3
1996
137
0.040
 Why?
Gene Expression Regulation
1
1990
2588
0.040
 Why?
Vaccines, Subunit
1
2021
53
0.040
 Why?
Immunoglobulins, Intravenous
1
2002
133
0.040
 Why?
Arylamine N-Acetyltransferase
1
2020
8
0.040
 Why?
Lymphoma
1
2002
233
0.040
 Why?
Cytochrome P-450 CYP2B6
1
2020
9
0.040
 Why?
Equivalence Trials as Topic
1
2020
35
0.040
 Why?
Pre-Eclampsia
1
2023
206
0.040
 Why?
Analysis of Variance
2
2016
1300
0.040
 Why?
Models, Statistical
1
2005
671
0.040
 Why?
Sentinel Lymph Node Biopsy
1
2001
117
0.040
 Why?
DNA
2
2006
1433
0.040
 Why?
Metabolic Clearance Rate
1
2020
115
0.040
 Why?
Living Donors
1
2023
281
0.040
 Why?
Surface Properties
1
2001
386
0.040
 Why?
Glioma
1
2005
429
0.040
 Why?
Spinal Cord
2
1994
382
0.040
 Why?
Central Nervous System Neoplasms
1
2002
177
0.040
 Why?
Trans-Activators
1
2002
396
0.040
 Why?
Lymphatic Metastasis
1
2001
331
0.040
 Why?
Heart Failure
3
1999
2324
0.040
 Why?
Alanine
1
2021
168
0.040
 Why?
Confusion
1
2020
30
0.040
 Why?
Cancer Vaccines
1
2001
161
0.040
 Why?
Hemodynamics
3
2001
1115
0.040
 Why?
Interleukin-3
3
1994
23
0.040
 Why?
Coronary Disease
2
2001
381
0.040
 Why?
Antibodies
1
2001
397
0.040
 Why?
Liver Function Tests
1
2019
105
0.040
 Why?
Candidiasis
1
1999
64
0.040
 Why?
Triiodothyronine
1
1999
54
0.040
 Why?
Prognosis
3
2024
4310
0.040
 Why?
Recombinant Fusion Proteins
2
1999
666
0.040
 Why?
California
2
2015
471
0.040
 Why?
Infant, Very Low Birth Weight
1
2019
75
0.040
 Why?
Hemagglutination
1
2018
7
0.040
 Why?
Macrophage-1 Antigen
1
1999
26
0.040
 Why?
Polymorphism, Single Nucleotide
3
2011
2136
0.040
 Why?
Hypoplastic Left Heart Syndrome
1
2000
117
0.040
 Why?
Mice, Inbred BALB C
1
2001
1261
0.040
 Why?
Arginine Vasopressin
1
1998
44
0.040
 Why?
Tenofovir
1
2021
300
0.040
 Why?
Cross-Sectional Studies
3
2024
5886
0.040
 Why?
Brain Diseases
1
2020
154
0.040
 Why?
Adenine
1
2021
338
0.030
 Why?
Neoplasms
3
2001
2900
0.030
 Why?
HLA-B Antigens
1
1998
58
0.030
 Why?
Chronic Disease
1
2024
1806
0.030
 Why?
Haptoglobins
1
2018
71
0.030
 Why?
Delivery, Obstetric
1
2019
160
0.030
 Why?
Antibody Specificity
1
1998
177
0.030
 Why?
Vasoconstrictor Agents
1
1998
150
0.030
 Why?
Immunization
1
2020
375
0.030
 Why?
Protein Precursors
1
2018
136
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2017
50
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Shock
1
1998
109
0.030
 Why?
Autogenic Training
1
1997
1
0.030
 Why?
Proviruses
1
2017
16
0.030
 Why?
Radioactive Fallout
1
1997
1
0.030
 Why?
Leukemia, Radiation-Induced
1
1997
4
0.030
 Why?
Product Surveillance, Postmarketing
1
2017
74
0.030
 Why?
Sequence Analysis
1
2017
34
0.030
 Why?
Radioactive Hazard Release
1
1997
5
0.030
 Why?
Observational Studies as Topic
1
2017
133
0.030
 Why?
Power Plants
1
1997
8
0.030
 Why?
Relaxation Therapy
1
1997
19
0.030
 Why?
Zambia
1
2017
58
0.030
 Why?
Tanzania
1
2017
72
0.030
 Why?
Reproducibility of Results
1
2005
3410
0.030
 Why?
Encephalitis
1
1998
142
0.030
 Why?
Ligands
1
1999
664
0.030
 Why?
Heart Valves
1
1997
44
0.030
 Why?
Lung Injury
1
2000
241
0.030
 Why?
Aortic Valve Insufficiency
1
1996
43
0.030
 Why?
Body Weight
1
2020
969
0.030
 Why?
Erythema
1
2016
28
0.030
 Why?
Prevalence
2
2018
2855
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
2016
29
0.030
 Why?
Up-Regulation
2
2001
846
0.030
 Why?
Neoplasms, Radiation-Induced
1
1997
100
0.030
 Why?
Fiber Optic Technology
1
2016
23
0.030
 Why?
Heart Arrest, Induced
1
1995
26
0.030
 Why?
Chi-Square Distribution
2
2013
527
0.030
 Why?
Thromboembolism
1
1996
129
0.030
 Why?
Vasodilation
1
1998
521
0.030
 Why?
Intestines
1
2018
354
0.030
 Why?
Graft vs Host Disease
1
1998
278
0.030
 Why?
Reference Values
2
2011
798
0.030
 Why?
Interleukin-4
2
1998
207
0.030
 Why?
DNA-Binding Proteins
1
2002
1479
0.030
 Why?
Single-Blind Method
1
2016
316
0.030
 Why?
Blood Transfusion
2
1995
407
0.030
 Why?
Ovulation
1
2015
46
0.030
 Why?
Registries
1
2024
2401
0.030
 Why?
Antibodies, Monoclonal
2
2001
1505
0.030
 Why?
Cross Infection
1
1997
260
0.030
 Why?
Hematologic Neoplasms
1
1997
168
0.030
 Why?
Liver
1
2023
1893
0.030
 Why?
Gene Regulatory Networks
1
2017
317
0.030
 Why?
Rats, Inbred BUF
1
1994
1
0.030
 Why?
Hypothermia, Induced
1
1995
95
0.030
 Why?
Blood Loss, Surgical
1
1995
112
0.030
 Why?
HLA-A2 Antigen
1
2014
36
0.030
 Why?
Pulmonary Emphysema
1
1996
277
0.030
 Why?
Surgical Wound Infection
1
1997
329
0.030
 Why?
Aortic Coarctation
1
1994
78
0.030
 Why?
Polymorphism, Restriction Fragment Length
2
2003
60
0.030
 Why?
Colony-Stimulating Factors
2
1990
37
0.020
 Why?
Cross-Over Studies
1
2016
608
0.020
 Why?
Aortic Valve
1
1996
364
0.020
 Why?
Quality of Life
4
2000
3194
0.020
 Why?
Myocardial Infarction
1
2001
1210
0.020
 Why?
Growth Substances
2
1990
138
0.020
 Why?
BK Virus
1
2013
18
0.020
 Why?
JC Virus
1
2013
23
0.020
 Why?
Cause of Death
3
2001
470
0.020
 Why?
Intubation, Intratracheal
1
2016
325
0.020
 Why?
Herpesviridae
1
2012
21
0.020
 Why?
Mice, Inbred Strains
2
1990
396
0.020
 Why?
Genetic Predisposition to Disease
2
2011
2351
0.020
 Why?
Drug Administration Schedule
2
2007
781
0.020
 Why?
Cardiac Surgical Procedures
1
1998
608
0.020
 Why?
Hypersensitivity, Delayed
1
1992
29
0.020
 Why?
Heart Diseases
1
1995
341
0.020
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
1990
161
0.020
 Why?
Brain Neoplasms
1
2001
1328
0.020
 Why?
Ventricular Function, Left
1
1995
539
0.020
 Why?
Spleen
1
1994
507
0.020
 Why?
Kaplan-Meier Estimate
1
2014
968
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
1958
0.020
 Why?
Sex Characteristics
1
2017
775
0.020
 Why?
Histocompatibility Antigens
1
1992
102
0.020
 Why?
Ambulatory Care
1
1996
608
0.020
 Why?
Patient Selection
1
1995
733
0.020
 Why?
Metabolomics
1
2017
730
0.020
 Why?
Computer Simulation
1
2016
1002
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Receptors, Interferon
1
2011
60
0.020
 Why?
Kidney Failure, Chronic
1
1997
599
0.020
 Why?
Cattle
2
1990
946
0.020
 Why?
Age of Onset
1
2012
554
0.020
 Why?
Administration, Oral
1
2013
862
0.020
 Why?
Radiotherapy
2
2005
204
0.020
 Why?
Stroke
1
2000
1270
0.020
 Why?
Polyribosomes
1
1990
22
0.020
 Why?
Cell Separation
1
2011
304
0.020
 Why?
Lung Neoplasms
2
2001
2662
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1990
156
0.020
 Why?
Concanavalin A
1
1990
72
0.020
 Why?
Tetradecanoylphorbol Acetate
1
1990
149
0.020
 Why?
Regulatory Sequences, Nucleic Acid
1
1990
92
0.020
 Why?
Blotting, Northern
1
1990
203
0.020
 Why?
Papillomaviridae
1
2010
115
0.020
 Why?
Haplotypes
1
2011
498
0.020
 Why?
Genetic Association Studies
1
2011
367
0.020
 Why?
Infant, Premature
1
2014
619
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
Cell Division
2
2002
753
0.020
 Why?
Practice Guidelines as Topic
1
2017
1579
0.020
 Why?
Mice, Knockout
2
2011
3114
0.020
 Why?
Herpesvirus 1, Bovine
1
1989
3
0.020
 Why?
Anxiety
1
1997
1117
0.020
 Why?
Immunoglobulin E
1
2010
315
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
749
0.020
 Why?
Hematopoietic Stem Cells
2
1990
418
0.020
 Why?
Reference Standards
1
2009
177
0.020
 Why?
Phylogeny
1
2013
917
0.020
 Why?
Ribosomes
1
1990
193
0.020
 Why?
Multiple Sclerosis
1
1994
487
0.020
 Why?
Linear Models
1
2010
844
0.020
 Why?
Infusions, Intravenous
2
1999
428
0.020
 Why?
Membrane Proteins
1
1994
1163
0.020
 Why?
Clinical Competence
1
2016
1240
0.020
 Why?
Time
1
2007
84
0.020
 Why?
Protein Biosynthesis
1
1990
451
0.020
 Why?
Drug Resistance, Multiple
1
2006
25
0.020
 Why?
Kidney Transplantation
1
2013
710
0.020
 Why?
Antineoplastic Agents
2
2010
2207
0.020
 Why?
Clinical Protocols
1
2007
280
0.010
 Why?
Templates, Genetic
1
2005
63
0.010
 Why?
Postoperative Care
2
1999
286
0.010
 Why?
Cell Differentiation
4
2000
2040
0.010
 Why?
Codon
1
2005
91
0.010
 Why?
Internship and Residency
1
2016
1264
0.010
 Why?
Interleukin-5
2
1998
39
0.010
 Why?
Diagnosis, Differential
1
2009
1506
0.010
 Why?
DNA Replication
1
2006
249
0.010
 Why?
Mice, Transgenic
2
2000
2185
0.010
 Why?
Age Distribution
1
2005
402
0.010
 Why?
Sex Distribution
1
2005
386
0.010
 Why?
Vaccines
1
2009
388
0.010
 Why?
Creatinine
2
1997
513
0.010
 Why?
Abdominal Neoplasms
1
2003
47
0.010
 Why?
Lung
1
1996
4101
0.010
 Why?
Endemic Diseases
1
2003
33
0.010
 Why?
Disease Progression
1
2010
2857
0.010
 Why?
Peptide Fragments
2
1998
693
0.010
 Why?
Sequence Analysis, DNA
1
2005
776
0.010
 Why?
Bioelectric Energy Sources
1
2001
4
0.010
 Why?
Neuroblastoma
1
2003
174
0.010
 Why?
Fibrosarcoma
1
2001
23
0.010
 Why?
Galvanic Skin Response
1
2001
26
0.010
 Why?
Electricity
1
2001
26
0.010
 Why?
Electric Conductivity
1
2001
85
0.010
 Why?
Actuarial Analysis
1
2001
16
0.010
 Why?
Injections, Intravenous
1
2001
197
0.010
 Why?
Melanoma, Experimental
1
2001
109
0.010
 Why?
Fingers
1
2001
107
0.010
 Why?
HLA-A Antigens
1
2001
52
0.010
 Why?
Myocardial Revascularization
1
2001
85
0.010
 Why?
Statistics, Nonparametric
1
2001
427
0.010
 Why?
Muscle, Smooth, Vascular
1
2003
445
0.010
 Why?
Immune Sera
1
2000
77
0.010
 Why?
Anticoagulants
2
1996
748
0.010
 Why?
Lymphocytes, Tumor-Infiltrating
1
2001
153
0.010
 Why?
Amino Acid Sequence
2
1994
2127
0.010
 Why?
Probability
1
2001
307
0.010
 Why?
Clone Cells
1
2000
263
0.010
 Why?
Mice, Inbred C57BL
2
2001
5972
0.010
 Why?
Emergency Treatment
1
2001
123
0.010
 Why?
Databases as Topic
1
2000
71
0.010
 Why?
New York
1
2000
128
0.010
 Why?
Carotid Artery Diseases
1
2000
70
0.010
 Why?
Students
1
2005
650
0.010
 Why?
Peripheral Vascular Diseases
1
2000
104
0.010
 Why?
Columbidae
1
1998
31
0.010
 Why?
Cytochrome c Group
1
1998
43
0.010
 Why?
Cardiotonic Agents
1
1999
94
0.010
 Why?
Lymph Nodes
1
2001
502
0.010
 Why?
Cardiac Output
1
1999
179
0.010
 Why?
Life Tables
1
1998
21
0.010
 Why?
Temperature
1
2001
632
0.010
 Why?
Endocardium
1
1998
31
0.010
 Why?
Aortic Diseases
1
2000
125
0.010
 Why?
Vascular Resistance
1
1999
369
0.010
 Why?
Calcinosis
1
2000
234
0.010
 Why?
Cell Death
1
1999
382
0.010
 Why?
Renal Insufficiency
1
2000
172
0.010
 Why?
Cardiopulmonary Bypass
1
2000
217
0.010
 Why?
Hypotension
1
1998
127
0.010
 Why?
Phosphorylation
1
2002
1706
0.010
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
1998
229
0.010
 Why?
Ukraine
1
1997
36
0.010
 Why?
Endocarditis, Bacterial
1
1997
46
0.010
 Why?
Odds Ratio
1
2000
1082
0.010
 Why?
Dose-Response Relationship, Drug
1
2001
2026
0.010
 Why?
Models, Structural
1
1996
41
0.010
 Why?
Lung Volume Measurements
1
1996
46
0.010
 Why?
Radiometry
1
1997
56
0.010
 Why?
Histocompatibility Antigens Class II
1
1998
364
0.010
 Why?
Epidemiologic Methods
1
1997
91
0.010
 Why?
Ultrasonography, Doppler, Transcranial
1
1996
48
0.010
 Why?
Health Care Costs
1
2000
425
0.010
 Why?
Cardiac Output, Low
1
1996
53
0.010
 Why?
Equipment Failure
1
1996
115
0.010
 Why?
Urogenital Neoplasms
1
1995
5
0.010
 Why?
Vital Capacity
1
1996
292
0.010
 Why?
Europe
1
1997
416
0.010
 Why?
Pneumonia, Viral
1
2001
388
0.010
 Why?
Neoplasms, Second Primary
1
1997
102
0.010
 Why?
Forced Expiratory Volume
1
1996
450
0.010
 Why?
Models, Cardiovascular
1
1996
195
0.010
 Why?
Blood Urea Nitrogen
1
1995
53
0.010
 Why?
Heart Valve Prosthesis
1
1997
129
0.010
 Why?
Aortic Aneurysm
1
1995
70
0.010
 Why?
Acute Disease
1
1998
1035
0.010
 Why?
Heart Rate
1
1999
855
0.010
 Why?
Child Development
1
2000
483
0.010
 Why?
Receptors, Antigen, T-Cell
1
1998
673
0.010
 Why?
Equipment Design
1
1996
525
0.010
 Why?
Biopsy
1
1998
1079
0.010
 Why?
Hodgkin Disease
1
1997
171
0.010
 Why?
Proportional Hazards Models
1
1998
1325
0.010
 Why?
Waiting Lists
1
1996
264
0.010
 Why?
Heart Septal Defects, Ventricular
1
1994
45
0.010
 Why?
Interviews as Topic
1
1997
907
0.010
 Why?
Reoperation
1
1997
630
0.010
 Why?
Exercise Test
1
1996
626
0.010
 Why?
Cell Adhesion
1
1994
451
0.010
 Why?
Myocardium
1
1998
931
0.010
 Why?
Thyroid Neoplasms
1
1997
350
0.010
 Why?
Smoking
1
2000
1470
0.010
 Why?
Ventricular Function, Right
1
1995
296
0.010
 Why?
Patient Compliance
1
1997
587
0.010
 Why?
Central Nervous System
1
1994
281
0.010
 Why?
Feasibility Studies
1
1996
1109
0.010
 Why?
Blood Pressure
1
1998
1778
0.010
 Why?
Diabetes Mellitus
1
2000
1092
0.010
 Why?
Head and Neck Neoplasms
1
1995
561
0.000
 Why?
Research Design
1
1997
1132
0.000
 Why?
Lymphocyte Cooperation
1
1990
50
0.000
 Why?
Receptors, Lymphocyte Homing
1
1990
15
0.000
 Why?
Thymectomy
1
1990
15
0.000
 Why?
Antilymphocyte Serum
1
1990
57
0.000
 Why?
Antigens, Surface
1
1990
155
0.000
 Why?
Rabbits
1
1990
652
0.000
 Why?
Infectious Bovine Rhinotracheitis
1
1989
1
0.000
 Why?
Phorbol Esters
1
1989
13
0.000
 Why?
Ionomycin
1
1989
22
0.000
 Why?
Ethers
1
1989
19
0.000
 Why?
Kidney
1
1997
1494
0.000
 Why?
Isoantigens
1
1988
17
0.000
 Why?
Immunotherapy
1
1994
665
0.000
 Why?
Cell-Free System
1
1988
53
0.000
 Why?
Surveys and Questionnaires
1
2000
6055
0.000
 Why?
Breast Neoplasms
1
1997
2380
0.000
 Why?
Models, Biological
1
1988
1763
0.000
 Why?
Weinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (834) concept(s)
_
Co-Authors Expand Description
See all (65) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)